{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T12:07:31Z","timestamp":1789214851266,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpagonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric and Adolescent Gynecology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jpag.2026.06.008","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:30:55Z","timestamp":1781105455000},"page":"594-601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Examining Structural and Social Drivers of Human Papillomavirus Vaccination Rates Across Clinical Settings for Youth"],"prefix":"10.1016","volume":"39","author":[{"given":"Anita","family":"Narkhede","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa","family":"Vidwans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Coughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa J.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jpag.2026.06.008_bib0001","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/OLQ.0000000000001356","article-title":"Estimated prevalence and incidence of disease-associated human papillomavirus types among 15- to 59-year-olds in the United States","volume":"48","author":"Lewis","year":"2021","journal-title":"Sex Transm Dis"},{"issue":"3","key":"10.1016\/j.jpag.2026.06.008_bib0002","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.2530","article-title":"Trends in human papillomavirus-associated cancers, demographic characteristics, and vaccinations in the US, 2001-2017","volume":"5","author":"Liao","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jpag.2026.06.008_bib0003","unstructured":"Prevention CfDCa. Cancers linked with HPV each year: Centers for Disease Control and Prevention; 2025. Available from: https:\/\/www.cdc.gov\/cancer\/hpv\/cases.html."},{"issue":"5","key":"10.1016\/j.jpag.2026.06.008_bib0004","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1080\/01443615.2019.1634030","article-title":"Human papillomavirus and cervical cancer","volume":"40","author":"Okunade","year":"2020","journal-title":"J Obstet Gynaecol"},{"issue":"1","key":"10.1016\/j.jpag.2026.06.008_bib0005","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/21645515.2018.1512453","article-title":"Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literature","volume":"15","author":"Hirth","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jpag.2026.06.008_bib0006","unstructured":"Group USCSW. U.S. Cancer Statistics Data Visualizations Tool: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2022. Available from: https:\/\/gis.cdc.gov\/Cancer\/USCS\/."},{"issue":"9686","key":"10.1016\/j.jpag.2026.06.008_bib0007","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.jpag.2026.06.008_bib0008","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"issue":"32","key":"10.1016\/j.jpag.2026.06.008_bib0009","doi-asserted-by":"crossref","first-page":"698","DOI":"10.15585\/mmwr.mm6832a3","article-title":"Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices","volume":"68","author":"Meites","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.jpag.2026.06.008_bib0010","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1097\/AOG.0000000000004000","article-title":"Human papillomavirus vaccination: ACOG Committee Opinion, Number 809","volume":"136","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.jpag.2026.06.008_bib0011","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3390\/vaccines12030228","article-title":"Unveiling the therapeutic horizon: HPV vaccines and their impact on cutaneous diseases\u2014a comprehensive review","volume":"12","author":"Sandru","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"5","key":"10.1016\/j.jpag.2026.06.008_bib0012","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15384","article-title":"Intralesional bivalent human papilloma virus vaccine as a treatment for anogenital warts versus topical podophyllin resin 25%: a pilot study","volume":"35","author":"Nofal","year":"2022","journal-title":"Dermatol Ther"},{"issue":"30","key":"10.1016\/j.jpag.2026.06.008_bib0013","doi-asserted-by":"crossref","first-page":"466","DOI":"10.15585\/mmwr.mm7430a1","article-title":"Vaccination coverage among adolescents aged 13-17 years\u2014National Immunization Survey-Teen, United States, 2024","volume":"74","author":"Pingali","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"20","key":"10.1016\/j.jpag.2026.06.008_bib0014","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1016\/j.vaccine.2022.03.028","article-title":"Disparities in human papillomavirus vaccination coverage in the United States, National Health and Nutrition Examination Survey, January 2017-March 2020","volume":"40","author":"Lewis","year":"2022","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jpag.2026.06.008_bib0015","first-page":"128","article-title":"Health inequities in human papillomavirus prevention, diagnostics and clinical care in the USA: a scoping review","volume":"99","author":"Magana","year":"2023","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jpag.2026.06.008_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2022.114871","article-title":"Human papillomavirus vaccination disparities among U.S. college students: an intersectional Multilevel Analysis of Individual Heterogeneity and Discriminatory Accuracy (MAIHDA)","volume":"301","author":"Zubizarreta","year":"2022","journal-title":"Soc Sci Med"},{"issue":"1","key":"10.1016\/j.jpag.2026.06.008_bib0017","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jamapediatrics.2013.2752","article-title":"Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature","volume":"168","author":"Holman","year":"2014","journal-title":"JAMA Pediatr"},{"issue":"9","key":"10.1016\/j.jpag.2026.06.008_bib0018","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/jamapediatrics.2024.2383","article-title":"Disparities in HPV vaccination among adolescents by health care facility type","volume":"178","author":"Nair","year":"2024","journal-title":"JAMA Pediatr"},{"issue":"suppl","key":"10.1016\/j.jpag.2026.06.008_bib0019","article-title":"Epidemiology and natural history of human papillomavirus infections in the female genital tract","volume":"2006","author":"Ault","year":"2006","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.jpag.2026.06.008_bib0020","article-title":"Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors","volume":"5","author":"Arbyn","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpag.2026.06.008_bib0021","unstructured":"Registry AfTSaD. Social vulnerability index. Available from: https:\/\/www.atsdr.cdc.gov\/place-health\/php\/svi\/index.html."},{"key":"10.1016\/j.jpag.2026.06.008_bib0022","doi-asserted-by":"crossref","DOI":"10.1177\/10732748241293674","article-title":"A cross-sectional analysis of 2017-2022 national immunization survey: sociodemographic disparities associated with human papillomavirus vaccine initiation and completion series among US adolescents","volume":"31","author":"Ibrahim-Ojoawo","year":"2024","journal-title":"Cancer Control"},{"issue":"5","key":"10.1016\/j.jpag.2026.06.008_bib0023","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.amepre.2021.04.031","article-title":"Factors associated with human papillomavirus vaccine series completion among adolescents","volume":"61","author":"Mansfield","year":"2021","journal-title":"Am J Prev Med"},{"issue":"38","key":"10.1016\/j.jpag.2026.06.008_bib0024","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.1016\/j.vaccine.2021.07.079","article-title":"Exploring socio-demographic and geospatial variation in human papillomavirus vaccination uptake in Virginia","volume":"39","author":"Staples","year":"2021","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.jpag.2026.06.008_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.05.042","article-title":"Exploration of individual socioeconomic and health-related characteristics associated with human papillomavirus vaccination initiation and vaccination series completion among adult females: a comprehensive systematic evidence review with meta-analysis","volume":"42","author":"Okoli","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.jpag.2026.06.008_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126560","article-title":"Human papillomavirus vaccination coverage among adolescent boys and girls in the United States: a birth year cohort analysis of the National Immunization Survey-Teen, 2016-2022","volume":"44","author":"Nyika","year":"2025","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.jpag.2026.06.008_bib0027","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.vaccine.2021.12.003","article-title":"Socioeconomic disadvantage and human papillomavirus (HPV) vaccination uptake","volume":"40","author":"Kurani","year":"2022","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.jpag.2026.06.008_bib0028","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/AOG.0000000000002802","article-title":"Disparities in human papillomavirus vaccine completion rates among females in an integrated health care system","volume":"132","author":"Freeman","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.jpag.2026.06.008_bib0029","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-056597","article-title":"Human papillomavirus vaccination trends among adolescents: 2015 to 2020","volume":"150","author":"Lu","year":"2022","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpag.2026.06.008_bib0030","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ypmed.2019.03.037","article-title":"Disparities and reverse disparities in HPV vaccination: a systematic review and meta-analysis","volume":"123","author":"Spencer","year":"2019","journal-title":"Prev Med"},{"issue":"6","key":"10.1016\/j.jpag.2026.06.008_bib0031","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-012765","article-title":"Trends in HPV vaccination initiation and completion within ages 9-12 years: 2008-2018","volume":"147","author":"Chido-Amajuoyi","year":"2021","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.jpag.2026.06.008_bib0032","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jadohealth.2015.10.009","article-title":"Preexisting chronic health conditions and health insurance status associated with vaccine receipt among adolescents","volume":"58","author":"Seib","year":"2016","journal-title":"J Adolesc Health"},{"issue":"24","key":"10.1016\/j.jpag.2026.06.008_bib0033","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1056\/NEJMoa2506765","article-title":"Noninferiority of one HPV vaccine dose to two doses","volume":"393","author":"Kreimer","year":"2025","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jpag.2026.06.008_bib0034","doi-asserted-by":"crossref","first-page":"e491","DOI":"10.1016\/S2214-109X(23)00586-7","article-title":"Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose in young women aged 15-20 years in Kenya (KEN SHE): an immunobridging analysis of randomised controlled trials","volume":"12","author":"Baisley","year":"2024","journal-title":"Lancet Glob Health"},{"issue":"11","key":"10.1016\/j.jpag.2026.06.008_bib0035","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S1470-2045(22)00543-5","article-title":"Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling study","volume":"23","author":"Man","year":"2022","journal-title":"Lancet Oncol"}],"container-title":["Journal of Pediatric and Adolescent Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083318826004225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083318826004225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:26:38Z","timestamp":1789212398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083318826004225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1083318826004225"],"URL":"https:\/\/doi.org\/10.1016\/j.jpag.2026.06.008","relation":{},"ISSN":["1083-3188"],"issn-type":[{"value":"1083-3188","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Examining Structural and Social Drivers of Human Papillomavirus Vaccination Rates Across Clinical Settings for Youth","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric and Adolescent Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpag.2026.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}